Tag: Alberto Ascherio
-
Nation & World
How coffee loves us back
Research at Harvard and elsewhere has repeatedly tied coffee consumption to health benefits.
-
Nation & World
Vitamin D could slow MS progression
For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health (HSPH) investigators in collaboration with Bayer HealthCare.
-
Nation & World
‘Sunshine vitamin’ looks a little brighter
Adequate levels of vitamin D during young adulthood could cut the risk of adult-onset type 1 diabetes by as much as 50 percent, according to new findings by researchers at the Harvard School of Public Health.
-
Nation & World
Study: Ibuprofen cuts Parkinson’s risk
A new study by Harvard School of Public Health researchers shows that adults who regularly take ibuprofen, a nonsteroidal anti-inflammatory drug, have about one-third less risk of developing Parkinson’s disease than nonusers.
-
Nation & World
Epstein-Barr Virus implicated as a cause of MS
Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple…
-
Nation & World
Body’s Own Antioxidant May Slow Parkinson’s Decline, Study Says
Today’s study “suggests a new approach in slowing down the rate of the disease,” said Schwarzschild, an associate professor of neurology at Harvard Medical School, in an Oct. 9 telephone interview. “People live with Parkinson’s disease for decades. We want to make those decades much more manageable and keep people much more mobile….”
-
Nation & World
Elevated urate levels may slow progression of Parkinson’s disease
Naturally elevated levels of the antioxidant urate may slow the progression of Parkinson’s disease in men. Researchers from the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) and Harvard School of Public…
-
Nation & World
Stronger evidence found linking Epstein-Barr virus and risk of multiple sclerosis
Researchers from the Harvard School of Public Health, Kaiser Permanente, and a team of collaborators have found further evidence implicating the Epstein-Barr virus (EBV) as a possible contributory cause to…
-
Nation & World
Anti-inflammatory drugs may reduce Parkinson’s disease risk
In the first study to investigate the potential benefit in humans of the use of non-steroidal anti-inflammatory drugs (NSAIDs) in reducing the risk of Parkinson’s disease, Harvard School of Public…
-
Nation & World
High levels of Epstein-Barr virus antibodies in women linked to risk of multiple sclerosis
Multiple sclerosis is a chronic degenerative disease of the central nervous system. Nationwide, there are an estimated 250,000 to 350,000 people with MS. Researchers have long wondered how MS develops…
-
Nation & World
Caffeine linked to protection from Parkinson’s disease
Parkinson’s disease is a progressive nervous disease occurring generally after age 50. It destroys brain cells that produce dopamine and is characterized by muscular tremor, slowing of movement, weakness and…
-
Nation & World
No link between hepatitis B vaccine and risk of multiple sclerosis
The French government in 1998 decided to temporarily suspend hepatitis B vaccine programs in schools after several cases of multiple sclerosis were reported a few weeks after the vaccine had…
-
Nation & World
Lowering iron levels does not cut heart attack risk for men
Men who give blood reduce the amount of iron in their bodies, but that does not result in a reduction in their risk of coronary heart disease (CHD) and heart…